Ellipsis Health is a San Francisco-based healthtech company developing AI-powered solutions for healthcare providers, health plans and care management organizations. Founded in 2017 by Mainul Mondal, Susan Solinsky and Michael Aratow, the company initially developed vocal biomarker technology to identify and measure signs of depression, anxiety and stress from speech. Its current product, Sage, is an AI care manager designed to automate patient engagement, assessments, enrollment and care-management interactions using conversational AI and Ellipsis Health's proprietary vocal biomarker technology.